LRCX Stock Up 24% after 10-Day Win Streak
Lam Research (LRCX) stock hit day 10 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 24% return. The company has gained about $37 Bil in value over the last 10 days, with its current market capitalization at about $154 Bil. The stock remains 67.7% above its value at the end of 2024. This compares with year-to-date returns of 12.3% for the S&P 500.
LRCX provides semiconductor processing equipment and services for integrated circuit fabrication to customers worldwide, including the US, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. After this rally, is LRCX still a buy – or is it time to lock in gains? Deep dive with Buy or Sell LRCX.
Comparing LRCX Stock Returns With The S&P 500
The following table summarizes the return for LRCX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | LRCX | S&P 500 |
|---|---|---|
| 1D | 1.1% | -0.1% |
| 10D (Current Streak) | 24.2% | 3.0% |
| 1M (21D) | 21.1% | 2.4% |
| 3M (63D) | 29.0% | 9.5% |
| YTD 2025 | 67.7% | 12.3% |
| 2024 | -6.8% | 23.3% |
| 2023 | 88.6% | 24.2% |
| 2022 | -40.7% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has LRCX behaved after prior drops? See LRCX Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 23 S&P constituents with 3 days or more of consecutive gains and 139 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 3 | 126 |
| 4D | 6 | 5 |
| 5D | 6 | 0 |
| 6D | 3 | 6 |
| 7D or more | 5 | 2 |
| Total >=3 D | 23 | 139 |
Key Financials for Lam Research (LRCX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $14.9 Bil | $18.4 Bil |
| Operating Income | $4.3 Bil | $5.9 Bil |
| Net Income | $3.8 Bil | $5.4 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $4.7 Bil | $5.2 Bil |
| Operating Income | $1.6 Bil | $1.7 Bil |
| Net Income | $1.3 Bil | $1.7 Bil |
While LRCX stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.